The University of Virginia Board of Visitors has approved new University Strategic Investment Fund expenditures that will support UVA Engineering’s vision for world-class research and education that provide solutions for a technologically advanced society. The newest investments are:
– A $17 million cross-disciplinary effort to end childhood diabetes, involving the School of Medicine, the School of Engineering, the Data Science Institute and the UVA-based Center for Diabetes Technology;
– A $6.4 million plan to create a world-class graduate engineering program, supporting 100 new and highly diverse engineering graduate students and enabling faculty to secure more external research funding and increase the body of highly cited work; and
– A $3 million boost in infrastructure that will support the development of novel and more effective tissue engineering and regenerative medicine technologies at the Center for Advanced Biomanufacturing.
The new investments follow Board of Visitors approval in September of $4.8 million to support UVA Engineering’s new Link Lab for cyber-physical systems research.
“This level of commitment from the Board of Visitors, combined with leadership, collaboration and visionary thinking from a broad range of our faculty and staff members, is positioning UVA Engineering to shape the future,” said Engineering Dean Craig Benson. “We will mobilize our significant strengths, pursuing internationally recognized research and education that deliver far-reaching benefits to society. I am grateful to all faculty and staff who participated in submitting proposals for Strategic Investment funding.”
UVA Engineering is in the process of hiring multiple new faculty members for cross-cutting research areas, along with graduate students to support the work. Learn more about open faculty positions at UVA’s jobs site.